Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Role of observational studies in assessing osteoporosis therapies: the REAL study.

Literature DB >> 22461217

Role of observational studies in assessing osteoporosis therapies: the REAL study.

Maria Luisa Brandi¹.

Abstract

Entities: Disease

Year: 2007 PMID： 22461217 PMCID： PMC2781239

Source DB: PubMed Journal: Clin Cases Miner Bone Metab ISSN： 1724-8914

Keyword Cloud
References

× No keyword cloud information.

12 in total

1. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group.

Authors: D M Black; D E Thompson; D C Bauer; K Ensrud; T Musliner; M C Hochberg; M C Nevitt; S Suryawanshi; S R Cummings
Journal: J Clin Endocrinol Metab Date: 2000-11 Impact factor: 5.958

Review 2. The use of claims databases for outcomes research: rationale, challenges, and strategies.

Authors: B R Motheral; K A Fairman
Journal: Clin Ther Date: 1997 Mar-Apr Impact factor: 3.393

Review 3. The crippling consequences of fractures and their impact on quality of life.

Authors: C Cooper
Journal: Am J Med Date: 1997-08-18 Impact factor: 4.965

4. Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey.

Authors: P Piscitelli; G Iolascon; F Gimigliano; M Muratore; P Camboa; O Borgia; B Forcina; F Fitto; V Robaud; G Termini; G B Rini; E Gianicolo; A Faino; M Rossini; S Adami; A Angeli; A Distante; S Gatto; R Gimigliano; G Guida
Journal: Osteoporos Int Date: 2006-10-24 Impact factor: 4.507

5. Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO study.

Authors: S Maggi; M Noale; S Giannini; S Adami; D Defeo; G Isaia; L Sinigaglia; P Filipponi; G Crepaldi
Journal: Osteoporos Int Date: 2005-09-02 Impact factor: 4.507

Role of observational studies in assessing osteoporosis therapies: the REAL study.

1. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group.

Review 2. The use of claims databases for outcomes research: rationale, challenges, and strategies.

Review 3. The crippling consequences of fractures and their impact on quality of life.

4. Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey.

5. Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO study.

6. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures.

7. Study subjects and ordinary patients.

Review 8. Osteoporosis: a still increasing prevalence.

9. Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis.

10. One year outcomes and costs following a vertebral fracture.